Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80066167
- Market status:
- Marketed
- Licence Status:
- Active
- Brand name(s):
-
M-HC 1% Protection cream
;
M-HC 1% Protection - Licence holder:
- Mantra Pharma Inc.
- Dosage Form:
- Cream
- Recommended route of administration:
-
Topical
Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
Adults and Children | 2 | year(s) | 0.0 | cream | 0 | daily | ||||||
Adults and Children | 12 | year(s) | 0.0 | cream | 0 | daily | ||||||
- Recommended use or purpose:
- For temporary relief of minor skin irritations associated with redness, itching, dryness and scaling. For temporary relief of minor skin irritations, rashes, itching and redness due to eczema, insect bites, poison ivy, poison oak, poison sumac, seborrheic dermatitis, psoriasis, or contact dermatitis (e.g. caused by soaps, detergents, cosmetics and/or jewellery). Anti-pruritic. Anti-itch. For temporary relief of external feminine genital itching and/or external anal itching due to hemorrhoids.
- Risk Information:
- Cautions and Warnings
- For external use only. Stop use and do not begin use of any other hydrocortisone product, except on the advice of a health care professional, if symptoms worsen or persist more than 7 days or clear up and occur again within a few days. For anal itching: Consult a health care professional promptly in case of bleeding.
- Contra-Indications
- Do not use this product in or around the eyes or on large areas of the body. Do not use this product for the treatment of diaper rash, except on the advice of a health care professional. For (external) feminine genital itching: Do not use this product to treat vulvar itching associated with a vaginal discharge, except on the advice of a health care professional
Medicinal ingredients | Quantity (Qty) | Extract | Potency |
---|---|---|---|
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione |
1.0 percent
|
- List of non-medicinal ingredients:
-
- Cyclopentasiloxane
- Dimethicone
- Microcrystalline Wax
- White petroleum jelly
- Date of licensing:
- 2015-12-31
- Revised date of licence:
- 2022-10-27
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).